<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet12893</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-12893</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль питания и состояния микрофлоры кишечника в формировании метаболического синдрома</article-title><trans-title-group xml:lang="en"><trans-title>Nutrition and the state of the intestinal microflora in the formation of the metabolic syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6219-5964</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Патракеева</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Patrakeeva</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Патракеева Вероника Павловна, кандидат биологических наук, ведущий научный сотрудник лаборатории экологической иммунологии Института физиологии природных адаптаций </p><p>163069, Архангельск, наб. Северной Двины, д. 23 </p><p>Researcher ID: AAV-1307-2020;</p><p>Scopus Author ID: 42962303300;</p><p>eLibrary SPIN: 9573-1094</p></bio><bio xml:lang="en"><p>Veronika P. Patrakeeva, PhD in biology</p><p>23 emb. Northern Dvina, 163069, Archangelsk</p><p>Researcher ID: AAV-1307-2020;</p><p>Scopus Author ID: 42962303300;</p><p>eLibrary SPIN: 9573-1094</p></bio><email xlink:type="simple">patrakeewa.veronika@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1142-4410</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Штаборов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shtaborov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Штаборов Вячеслав Анатольевич, кандидат биологических наук , старший научный сотрудник лаборатории экологической иммунологии Института физиологии природных адаптаций </p><p>Архангельск</p><p>eLibrary SPIN: 9519-4149</p></bio><bio xml:lang="en"><p>Vyacheslav A. Shtaborov, PhD in biology</p><p>Archangelsk</p><p>eLibrary SPIN: 9519-4149</p></bio><email xlink:type="simple">schtaborov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральный исследовательский центр комплексного изучения Арктики имени академика Н.П. Лаверова Уральского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>08</month><year>2022</year></pub-date><volume>19</volume><issue>3</issue><fpage>292</fpage><lpage>299</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Патракеева В.П., Штаборов В.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Патракеева В.П., Штаборов В.А.</copyright-holder><copyright-holder xml:lang="en">Patrakeeva V.P., Shtaborov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/12893">https://www.omet-endojournals.ru/jour/article/view/12893</self-uri><abstract><p>В обзоре литературы представлены результаты современных исследований взаимосвязи рациона питания и микробиоты кишечника в регуляции метаболических нарушений. Метаболический синдром, представляющий собой симптомокомплекс, сочетающий абдоминальное ожирение, инсулинорезистентность, гипергликемию, дислипидемию и артериальную гипертензию, остается важной проблемой, являясь фактором риска сердечно-сосудистых, нейродегенеративных, онкологических заболеваний и развития сахарного диабета 2 типа. Хотя патогенез метаболического синдрома пока полностью не выяснен, известно, что центральную роль играют висцеральное ожирение и связанные с ним осложнения, такие как дислипидемия и повышение уровня провоспалительных цитокинов. В статье представлены данные о влиянии употребления определенных продуктов питания, включения в рацион растительных биологически активных веществ (флавоноиды, полифенолы и др.), а также применения элиминационных диет с исключением из рациона питания углеводов или жиров, на снижение показателей риска сердечно-сосудистых катастроф, уровней глюкозы натощак, общего холестерина, липопротеинов низкой плотности, триглицеридов, С-реактивного белка, лептина, инсулина, массы тела и окружности талии, уровня циркулирующих эндотоксинов и изменение активности иммунокомпетентных клеток. Представлены данные о возможном влиянии микробиоты кишечника в поддержании воспаления и формировании дегенеративных изменений в организме. Показана роль изменения соотношения уровней патогенной микрофлоры, бифидои лактобактерий при формировании патологического состояния.</p><p>  </p></abstract><trans-abstract xml:lang="en"><p>The literature review presents the results of modern studies of the relationship between diet and intestinal microbiota in the regulation of metabolic disorders. Metabolic syndrome, which is a symptom complex that combines abdominal obesity, insulin resistance, hyperglycemia, dyslipidemia and arterial hypertension, remains an important problem, being a risk factor for cardiovascular, neurodegenerative, oncological diseases and the development of type 2 diabetes mellitus. Although the pathogenesis of the metabolic syndrome has not yet been fully elucidated, it is known that visceral obesity and its associated complications, such as dyslipidemia and increased levels of pro-inflammatory cytokines, play a central role. The article presents data on the impact of the consumption of certain food products, the inclusion of plant biologically active substances (flavonoids, polyphenols, etc.) in the diet, as well as the use of elimination diets with the exclusion of carbohydrates or fats from the diet, on reducing the risk of cardiovascular accidents, levels of fasting glucose, total cholesterol, LDL, triglycerides, C-reactive protein, leptin, insulin, reduction in body weight and waist circumference, reduction in the level of circulating endotoxins and changes in the activity of immunocompetent cells. Data are presented on the possible influence of the intestinal microbiota in maintaining inflammation and the formation of degenerative changes in the body. The role of changes in the ratio of the levels of pathogenic microflora, bifidobacteria and lactobacilli in the formation of a pathological condition is shown.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>метаболический синдром</kwd><kwd>ожирение</kwd><kwd>питание</kwd><kwd>микрофлора кишечника</kwd><kwd>воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metabolic syndrome</kwd><kwd>obesity</kwd><kwd>nutrition</kwd><kwd>intestinal microflora</kwd><kwd>inflammation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет средств гранта РНФ № 22-25-20145 «Выяснение механизмов влияния снижения толерантности к пищевым антигенам на утилизацию глюкозы»</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Avwioroko OJ, Anigboro AA, Otuechere CA, et al. α-Amylase inhibition, anti-glycation property and characterization of the binding interaction of citric acid with α-amylase using multiple spectroscopic, kinetics and molecular docking approaches. J Mol Liq. 2022;360(6):119454. doi: https://doi.org/10.1016/j.molliq.2022.119454</mixed-citation><mixed-citation xml:lang="en">Avwioroko OJ, Anigboro AA, Otuechere CA, et al. α-Amylase inhibition, anti-glycation property and characterization of the binding interaction of citric acid with α-amylase using multiple spectroscopic, kinetics and molecular docking approaches. J Mol Liq. 2022;360(6):119454. doi: https://doi.org/10.1016/j.molliq.2022.119454</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Szabó K, Maccari R, Ottanà R, Gyémánt G. Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: A study with pancreatic α-amylase. Carbohydr Res. 2021;499:108220. doi: https://doi.org/10.1016/j.carres.2020.108220</mixed-citation><mixed-citation xml:lang="en">Szabó K, Maccari R, Ottanà R, Gyémánt G. Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: A study with pancreatic α-amylase. Carbohydr Res. 2021;499:108220. doi: https://doi.org/10.1016/j.carres.2020.108220</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">van Meijl LEC, Vrolix R, Mensink RP. Dairy product consumption and the metabolic syndrome. Nutr Res Rev. 2008;21(2):148-157. doi: https://doi.org/10.1017/S0954422408116997</mixed-citation><mixed-citation xml:lang="en">van Meijl LEC, Vrolix R, Mensink RP. Dairy product consumption and the metabolic syndrome. Nutr Res Rev. 2008;21(2):148-157. doi: https://doi.org/10.1017/S0954422408116997</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Khorraminezhad L, Bilodeau J-F, Greffard K, Larose J, Rudkowska I. Impact of Dairy Intake on Plasma F2-IsoProstane Profiles in Overweight Subjects with Hyperinsulinemia: A Randomized Crossover Trial. Nutrients. 2021;13(6):2088. doi: https://doi.org/10.3390/nu13062088</mixed-citation><mixed-citation xml:lang="en">Khorraminezhad L, Bilodeau J-F, Greffard K, Larose J, Rudkowska I. Impact of Dairy Intake on Plasma F2-IsoProstane Profiles in Overweight Subjects with Hyperinsulinemia: A Randomized Crossover Trial. Nutrients. 2021;13(6):2088. doi: https://doi.org/10.3390/nu13062088</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wennersberg MH, Smedman A, Turpeinen AM, et al. Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr. 2009;90(4):960-968. doi: https://doi.org/10.3945/ajcn.2009.27664</mixed-citation><mixed-citation xml:lang="en">Wennersberg MH, Smedman A, Turpeinen AM, et al. Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr. 2009;90(4):960-968. doi: https://doi.org/10.3945/ajcn.2009.27664</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts CK, Won D, Pruthi S, et al. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006;100(5):1657-1665. doi: https://doi.org/10.1152/japplphysiol.01292.2005</mixed-citation><mixed-citation xml:lang="en">Roberts CK, Won D, Pruthi S, et al. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006;100(5):1657-1665. doi: https://doi.org/10.1152/japplphysiol.01292.2005</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Xie Y, Su X, et al. Inonotus sanghuang Polyphenols Attenuate Inflammatory Response Via Modulating the Crosstalk Between Macrophages and Adipocytes. Front Immunol. 2019;10(5):1657-1665. doi: https://doi.org/10.3389/fimmu.2019.00286</mixed-citation><mixed-citation xml:lang="en">Zhang M, Xie Y, Su X, et al. Inonotus sanghuang Polyphenols Attenuate Inflammatory Response Via Modulating the Crosstalk Between Macrophages and Adipocytes. Front Immunol. 2019;10(5):1657-1665. doi: https://doi.org/10.3389/fimmu.2019.00286</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Teixeira R de CM de A, Molina M del CB, Zandonade E, Mill JG. Risco cardiovascular em vegetarianos e onívoros: um estudo comparativo. Arq Bras Cardiol. 2007;89(4):1657-1665. doi: https://doi.org/10.1590/S0066-782X2007001600005</mixed-citation><mixed-citation xml:lang="en">Teixeira R de CM de A, Molina M del CB, Zandonade E, Mill JG. Risco cardiovascular em vegetarianos e onívoros: um estudo comparativo. Arq Bras Cardiol. 2007;89(4):1657-1665. doi: https://doi.org/10.1590/S0066-782X2007001600005</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yokoyama Y, Barnard ND, Levin SM, Watanabe M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther. 2014;4(5):373-382. doi: https://doi.org/10.3978/j.issn.2223-3652.2014.10.04</mixed-citation><mixed-citation xml:lang="en">Yokoyama Y, Barnard ND, Levin SM, Watanabe M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther. 2014;4(5):373-382. doi: https://doi.org/10.3978/j.issn.2223-3652.2014.10.04</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Barnard ND, Levin SM, Yokoyama Y. A systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets. J Acad Nutr Diet. 2015;115(6):954-69. doi: https://doi.org/10.1016/j.jand.2014.11.016.</mixed-citation><mixed-citation xml:lang="en">Barnard ND, Levin SM, Yokoyama Y. A systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets. J Acad Nutr Diet. 2015;115(6):954-69. doi: https://doi.org/10.1016/j.jand.2014.11.016.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Huang R-Y, Huang C-C, Hu FB, Chavarro JE. Vegetarian Diets and Weight Reduction: a Meta-Analysis of Randomized Controlled Trials. J Gen Intern Med. 2016;31(1):109-116. doi: https://doi.org/10.1007/s11606-015-3390-7</mixed-citation><mixed-citation xml:lang="en">Huang R-Y, Huang C-C, Hu FB, Chavarro JE. Vegetarian Diets and Weight Reduction: a Meta-Analysis of Randomized Controlled Trials. J Gen Intern Med. 2016;31(1):109-116. doi: https://doi.org/10.1007/s11606-015-3390-7</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Baden MY, Satija A, Hu FB, Huang T. Change in Plant-Based Diet Quality Is Associated with Changes in Plasma Adiposity-Associated Biomarker Concentrations in Women. J Nutr. 2019;149(4):676-686. doi: https://doi.org/10.1093/jn/nxy301</mixed-citation><mixed-citation xml:lang="en">Baden MY, Satija A, Hu FB, Huang T. Change in Plant-Based Diet Quality Is Associated with Changes in Plasma Adiposity-Associated Biomarker Concentrations in Women. J Nutr. 2019;149(4):676-686. doi: https://doi.org/10.1093/jn/nxy301</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H, Lee K, Rebholz CM, Kim J. Plant-based diets and incident metabolic syndrome: Results from a South Korean prospective cohort study. PLOS Med. 2020;17(11):e1003371. doi: https://doi.org/10.1371/journal.pmed.1003371</mixed-citation><mixed-citation xml:lang="en">Kim H, Lee K, Rebholz CM, Kim J. Plant-based diets and incident metabolic syndrome: Results from a South Korean prospective cohort study. PLOS Med. 2020;17(11):e1003371. doi: https://doi.org/10.1371/journal.pmed.1003371</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mc Grath L, Fernandez M-L. Plant-based diets and metabolic syndrome: Evaluating the influence of diet quality. Journal of Agriculture and Food Research. 2022;9:100322. https://doi.org/10.1016/j.jafr.2022.100322</mixed-citation><mixed-citation xml:lang="en">Mc Grath L, Fernandez M-L. Plant-based diets and metabolic syndrome: Evaluating the influence of diet quality. Journal of Agriculture and Food Research. 2022;9:100322. https://doi.org/10.1016/j.jafr.2022.100322</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Anhê FF, Varin T V., Le Barz M, et al. Arctic berry extracts target the gut–liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice. Diabetologia. 2018;61(4):919-931. doi: https://doi.org/10.1007/s00125-017-4520-z</mixed-citation><mixed-citation xml:lang="en">Anhê FF, Varin T V., Le Barz M, et al. Arctic berry extracts target the gut– liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice. Diabetologia. 2018;61(4):919-931. doi: https://doi.org/10.1007/s00125-017-4520-z</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">del Cornò M, Scazzocchio B, Masella R, Gessani S. Regulation of Dendritic Cell Function by Dietary Polyphenols. Crit Rev Food Sci Nutr. 2016;56(5):737-747. doi: https://doi.org/10.1080/10408398.2012.713046</mixed-citation><mixed-citation xml:lang="en">del Cornò M, Scazzocchio B, Masella R, Gessani S. Regulation of Dendritic Cell Function by Dietary Polyphenols. Crit Rev Food Sci Nutr. 2016;56(5):737-747. doi: https://doi.org/10.1080/10408398.2012.713046</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Buttari B, Profumo E, Facchiano F, et al. Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products. Oxid Med Cell Longev. 2013;2013(4):1-12. doi: https://doi.org/10.1155/2013/574029</mixed-citation><mixed-citation xml:lang="en">Buttari B, Profumo E, Facchiano F, et al. Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products. Oxid Med Cell Longev. 2013;2013(4):1-12. doi: https://doi.org/10.1155/2013/574029</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dugo L, Belluomo MG, Fanali C, et al. Effect of Cocoa Polyphenolic Extract on Macrophage Polarization from Proinflammatory M1 to Anti-Inflammatory M2 State. Oxid Med Cell Longev. 2017;2017(4):1-11. doi: https://doi.org/10.1155/2017/6293740</mixed-citation><mixed-citation xml:lang="en">Dugo L, Belluomo MG, Fanali C, et al. Effect of Cocoa Polyphenolic Extract on Macrophage Polarization from Proinflammatory M1 to Anti-Inflammatory M2 State. Oxid Med Cell Longev. 2017;2017(4):1-11. doi: https://doi.org/10.1155/2017/6293740</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Xie Y, Su X, et al. Inonotus sanghuang Polyphenols Attenuate Inflammatory Response Via Modulating the Crosstalk Between Macrophages and Adipocytes. Front Immunol. 2019;10(4):1-11. doi: https://doi.org/10.3389/fimmu.2019.00286</mixed-citation><mixed-citation xml:lang="en">Zhang M, Xie Y, Su X, et al. Inonotus sanghuang Polyphenols Attenuate Inflammatory Response Via Modulating the Crosstalk Between Macrophages and Adipocytes. Front Immunol. 2019;10(4):1-11. doi: https://doi.org/10.3389/fimmu.2019.00286</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shakoor H, Feehan J, Apostolopoulos V, et al. Immunomodulatory Effects of Dietary Polyphenols. Nutrients. 2021;13(3):728. doi: https://doi.org/10.3390/nu13030728</mixed-citation><mixed-citation xml:lang="en">Shakoor H, Feehan J, Apostolopoulos V, et al. Immunomodulatory Effects of Dietary Polyphenols. Nutrients. 2021;13(3):728. doi: https://doi.org/10.3390/nu13030728</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yahfoufi N, Alsadi N, Jambi M, Matar C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients. 2018;10(11):1618. doi: https://doi.org/10.3390/nu10111618</mixed-citation><mixed-citation xml:lang="en">Yahfoufi N, Alsadi N, Jambi M, Matar C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients. 2018;10(11):1618. doi: https://doi.org/10.3390/nu10111618</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon E-Y, Choi M-S. Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. Nutrients. 2018;10(10):1415. doi: https://doi.org/10.3390/nu10101415</mixed-citation><mixed-citation xml:lang="en">Kwon E-Y, Choi M-S. Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. Nutrients. 2018;10(10):1415. doi: https://doi.org/10.3390/nu10101415</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jabri M-A, Rtibi K, Sebai H. Chamomile decoction mitigates high fat diet-induced anxiety-like behavior, neuroinflammation and cerebral ROS overload. Nutr Neurosci. 2022;25(7):1350-1361. doi: https://doi.org/10.1080/1028415X.2020.1859727</mixed-citation><mixed-citation xml:lang="en">Jabri M-A, Rtibi K, Sebai H. Chamomile decoction mitigates high fat diet-induced anxiety-like behavior, neuroinflammation and cerebral ROS overload. Nutr Neurosci. 2022;25(7):1350-1361. doi: https://doi.org/10.1080/1028415X.2020.1859727</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Villa-Rodriguez JA, Kerimi A, Abranko L, et al. Acute metabolic actions of the major polyphenols in chamomile: an in vitro mechanistic study on their potential to attenuate postprandial hyperglycaemia. Sci Rep. 2018;8(1):5471. doi: https://doi.org/10.1038/s41598-018-23736-1</mixed-citation><mixed-citation xml:lang="en">Villa-Rodriguez JA, Kerimi A, Abranko L, et al. Acute metabolic actions of the major polyphenols in chamomile: an in vitro mechanistic study on their potential to attenuate postprandial hyperglycaemia. Sci Rep. 2018;8(1):5471. doi: https://doi.org/10.1038/s41598-018-23736-1</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Franco EPD de, Contesini FJ, Lima da Silva B, et al. Enzymeassisted modification of flavonoids from Matricaria chamomilla : antioxidant activity and inhibitory effect on digestive enzymes. J Enzyme Inhib Med Chem. 2020;35(1):42-49. doi: https://doi.org/10.1080/14756366.2019.1681989</mixed-citation><mixed-citation xml:lang="en">Franco EPD de, Contesini FJ, Lima da Silva B, et al. Enzymeassisted modification of flavonoids from Matricaria chamomilla : antioxidant activity and inhibitory effect on digestive enzymes. J Enzyme Inhib Med Chem. 2020;35(1):42-49. doi: https://doi.org/10.1080/14756366.2019.1681989</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Herrera-Balandrano DD, Chai Z, Hutabarat RP, et al. Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: In vitro and in vivo studies. Redox Biol. 2021;46(1):102100. doi: https://doi.org/10.1016/j.redox.2021.102100</mixed-citation><mixed-citation xml:lang="en">Herrera-Balandrano DD, Chai Z, Hutabarat RP, et al. Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: In vitro and in vivo studies. Redox Biol. 2021;46(1):102100. doi: https://doi.org/10.1016/j.redox.2021.102100</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rufino AT, Costa VM, Carvalho F, Fernandes E. Flavonoids as antiobesity agents: A review. Med Res Rev. 2021;41(1):556-585. doi: https://doi.org/10.1002/med.21740</mixed-citation><mixed-citation xml:lang="en">Rufino AT, Costa VM, Carvalho F, Fernandes E. Flavonoids as antiobesity agents: A review. Med Res Rev. 2021;41(1):556-585. doi: https://doi.org/10.1002/med.21740</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ju M, Liu Y, Li M, et al. Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet. Eur J Pharmacol. 2019;857(1):172457. doi: https://doi.org/10.1016/j.ejphar.2019.172457</mixed-citation><mixed-citation xml:lang="en">Ju M, Liu Y, Li M, et al. Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet. Eur J Pharmacol. 2019;857(1):172457. doi: https://doi.org/10.1016/j.ejphar.2019.172457</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Tian L, Tan Y, Chen G, et al. Metabolism of anthocyanins and consequent effects on the gut microbiota. Crit Rev Food Sci Nutr. 2019;59(6):982-991. doi: https://doi.org/10.1080/10408398.2018.1533517</mixed-citation><mixed-citation xml:lang="en">Tian L, Tan Y, Chen G, et al. Metabolism of anthocyanins and consequent effects on the gut microbiota. Crit Rev Food Sci Nutr. 2019;59(6):982-991. doi: https://doi.org/10.1080/10408398.2018.1533517</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lin Y, Wang Z-Y, Wang M-J, et al. Baicalin attenuate diet-induced metabolic syndrome by improving abnormal metabolism and gut microbiota. Eur J Pharmacol. 2022;925(6):174996. doi: https://doi.org/10.1016/j.ejphar.2022.174996</mixed-citation><mixed-citation xml:lang="en">Lin Y, Wang Z-Y, Wang M-J, et al. Baicalin attenuate diet-induced metabolic syndrome by improving abnormal metabolism and gut microbiota. Eur J Pharmacol. 2022;925(6):174996. doi: https://doi.org/10.1016/j.ejphar.2022.174996</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Baek Y, Lee MN, Wu D, Pae M. Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice. J Nutr Biochem. 2019;71(6):72-81. doi: https://doi.org/10.1016/j.jnutbio.2019.06.002</mixed-citation><mixed-citation xml:lang="en">Baek Y, Lee MN, Wu D, Pae M. Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice. J Nutr Biochem. 2019;71(6):72-81. doi: https://doi.org/10.1016/j.jnutbio.2019.06.002</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Seshadri P, Iqbal N, Stern L, et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004;117(6):398-405. doi: https://doi.org/10.1016/j.amjmed.2004.04.009</mixed-citation><mixed-citation xml:lang="en">Seshadri P, Iqbal N, Stern L, et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004;117(6):398-405. doi: https://doi.org/10.1016/j.amjmed.2004.04.009</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Feinman RD, Volek JS. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scand Cardiovasc J. 2008;42(4):256-263. doi: https://doi.org/10.1080/14017430802014838</mixed-citation><mixed-citation xml:lang="en">Feinman RD, Volek JS. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scand Cardiovasc J. 2008;42(4):256-263. doi: https://doi.org/10.1080/14017430802014838</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond). 2005;2(1):31. doi: https://doi.org/10.1186/1743-7075-2-31</mixed-citation><mixed-citation xml:lang="en">Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond). 2005;2(1):31. doi: https://doi.org/10.1186/1743-7075-2-31</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen MTA, Favelyukis S, Nguyen A-K, et al. A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways. J Biol Chem. 2007;282(48):35279-35292. doi: https://doi.org/10.1074/jbc.M706762200</mixed-citation><mixed-citation xml:lang="en">Nguyen MTA, Favelyukis S, Nguyen A-K, et al. A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways. J Biol Chem. 2007;282(48):35279-35292. doi: https://doi.org/10.1074/jbc.M706762200</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A. Lipotoxicity: Effects of Dietary Saturated and Transfatty Acids. Mediators Inflamm. 2013;2013(48):1-13. doi: https://doi.org/10.1155/2013/137579</mixed-citation><mixed-citation xml:lang="en">Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A. Lipotoxicity: Effects of Dietary Saturated and Transfatty Acids. Mediators Inflamm. 2013;2013(48):1-13. doi: https://doi.org/10.1155/2013/137579</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Micha R, Mozaffarian D. Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence. Lipids. 2010;45(10):893-905. doi: https://doi.org/10.1007/s11745-010-3393-4</mixed-citation><mixed-citation xml:lang="en">Micha R, Mozaffarian D. Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence. Lipids. 2010;45(10):893-905. doi: https://doi.org/10.1007/s11745-010-3393-4</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Tinker LF. Low-Fat Dietary Pattern and Risk of Treated Diabetes Mellitus in Postmenopausal WomenThe Women’s Health Initiative Randomized Controlled Dietary Modification Trial. Arch Intern Med. 2008;168(14):1500. doi: https://doi.org/10.1001/archinte.168.14.1500</mixed-citation><mixed-citation xml:lang="en">Tinker LF. Low-Fat Dietary Pattern and Risk of Treated Diabetes Mellitus in Postmenopausal WomenThe Women’s Health Initiative Randomized Controlled Dietary Modification Trial. Arch Intern Med. 2008;168(14):1500. doi: https://doi.org/10.1001/archinte.168.14.1500</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sluijs I, Forouhi NG, Beulens JW, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96(2):382-390. doi: https://doi.org/10.3945/ajcn.111.021907</mixed-citation><mixed-citation xml:lang="en">Sluijs I, Forouhi NG, Beulens JW, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96(2):382-390. doi: https://doi.org/10.3945/ajcn.111.021907</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connor LM, Lentjes MAH, Luben RN, et al. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia. 2014;57(5):909-917. doi: https://doi.org/10.1007/s00125-014-3176-1</mixed-citation><mixed-citation xml:lang="en">O’Connor LM, Lentjes MAH, Luben RN, et al. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia. 2014;57(5):909-917. doi: https://doi.org/10.1007/s00125-014-3176-1</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct casecohort study. Lancet Diabetes Endocrinol. 2014;2(10):810-818. doi: https://doi.org/10.1016/S2213-8587(14)70146-9</mixed-citation><mixed-citation xml:lang="en">Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct casecohort study. Lancet Diabetes Endocrinol. 2014;2(10):810-818. doi: https://doi.org/10.1016/S2213-8587(14)70146-9</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Eilat-Adar S, Loria C, et al. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr. 2006;84(4):894-902. doi: https://doi.org/10.1093/ajcn/84.4.894</mixed-citation><mixed-citation xml:lang="en">Xu J, Eilat-Adar S, Loria C, et al. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr. 2006;84(4):894-902. doi: https://doi.org/10.1093/ajcn/84.4.894</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lamarche B, Couture P. It is time to revisit current dietary recommendations for saturated fat. Appl Physiol Nutr Metab. 2014;39(12):1409-1411. doi: https://doi.org/10.1139/apnm-2014-0141</mixed-citation><mixed-citation xml:lang="en">Lamarche B, Couture P. It is time to revisit current dietary recommendations for saturated fat. Appl Physiol Nutr Metab. 2014;39(12):1409-1411. doi: https://doi.org/10.1139/apnm-2014-0141</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535-546. doi: https://doi.org/10.3945/ajcn.2009.27725</mixed-citation><mixed-citation xml:lang="en">Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535-546. doi: https://doi.org/10.3945/ajcn.2009.27725</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Atkinson FS, Brand-Miller JC, Foster-Powell K, et al. International tables of glycemic index and glycemic load values 2021: a systematic review. Am J Clin Nutr. 2021;114(5):1625-1632. doi: https://doi.org/10.1093/ajcn/nqab233</mixed-citation><mixed-citation xml:lang="en">Atkinson FS, Brand-Miller JC, Foster-Powell K, et al. International tables of glycemic index and glycemic load values 2021: a systematic review. Am J Clin Nutr. 2021;114(5):1625-1632. doi: https://doi.org/10.1093/ajcn/nqab233</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Goff LM, Cowland DE, Hooper L, Frost GS. Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2013;23(1):1-10. doi: https://doi.org/10.1016/j.numecd.2012.06.002</mixed-citation><mixed-citation xml:lang="en">Goff LM, Cowland DE, Hooper L, Frost GS. Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2013;23(1):1-10. doi: https://doi.org/10.1016/j.numecd.2012.06.002</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2013;23(8):699-706. doi: https://doi.org/10.1016/j.numecd.2013.04.008</mixed-citation><mixed-citation xml:lang="en">Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2013;23(8):699-706. doi: https://doi.org/10.1016/j.numecd.2013.04.008</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Jun S, Lee S, Lee J, Kim J. Diets high in glycemic index and glycemic load are associated with an increased risk of metabolic syndrome among Korean women. Nutr Metab Cardiovasc Dis. 2022;32(5):1154-1164. doi: https://doi.org/10.1016/j.numecd.2022.01.017</mixed-citation><mixed-citation xml:lang="en">Jun S, Lee S, Lee J, Kim J. Diets high in glycemic index and glycemic load are associated with an increased risk of metabolic syndrome among Korean women. Nutr Metab Cardiovasc Dis. 2022;32(5):1154-1164. doi: https://doi.org/10.1016/j.numecd.2022.01.017</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Pan Y, Pratt CA. Metabolic Syndrome and Its Association with Diet and Physical Activity in US Adolescents. J Am Diet Assoc. 2008;108(2):276-286. doi: https://doi.org/10.1016/j.jada.2007.10.049</mixed-citation><mixed-citation xml:lang="en">Pan Y, Pratt CA. Metabolic Syndrome and Its Association with Diet and Physical Activity in US Adolescents. J Am Diet Assoc. 2008;108(2):276-286. doi: https://doi.org/10.1016/j.jada.2007.10.049</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Hooshmand F, Asghari G, Yuzbashian E, et al. Modified Healthy Eating Index and Incidence of Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study. J Pediatr. 2018;197(2):134-139.e2. doi: https://doi.org/10.1016/j.jpeds.2018.01.080</mixed-citation><mixed-citation xml:lang="en">Hooshmand F, Asghari G, Yuzbashian E, et al. Modified Healthy Eating Index and Incidence of Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study. J Pediatr. 2018;197(2):134-139.e2. doi: https://doi.org/10.1016/j.jpeds.2018.01.080</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Kehoe SH, Krishnaveni G V., Veena S, et al. Active children are less adipose and insulin resistant in early adolescence; evidence from the Mysore Parthenon Cohort. BMC Pediatr. 2019;19(1):503. doi: https://doi.org/10.1186/s12887-019-1855-2</mixed-citation><mixed-citation xml:lang="en">Kehoe SH, Krishnaveni G V., Veena S, et al. Active children are less adipose and insulin resistant in early adolescence; evidence from the Mysore Parthenon Cohort. BMC Pediatr. 2019;19(1):503. doi: https://doi.org/10.1186/s12887-019-1855-2</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Summer SS, Jenkins T, Inge T, et al. Association of diet quality, physical activity, and abdominal obesity with metabolic syndrome z-score in black and white adolescents in the US. Nutr Metab Cardiovasc Dis. 2022;32(2):346-354. doi: https://doi.org/10.1016/j.numecd.2021.10.021</mixed-citation><mixed-citation xml:lang="en">Summer SS, Jenkins T, Inge T, et al. Association of diet quality, physical activity, and abdominal obesity with metabolic syndrome z-score in black and white adolescents in the US. Nutr Metab Cardiovasc Dis. 2022;32(2):346-354. doi: https://doi.org/10.1016/j.numecd.2021.10.021</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Кажина М.В. Беременность на фоне ожирения: дебют метаболического синдрома матери и программирование метаболического синдрома плода // Охрана материнства и детства. — 2018. — Т. 1 — №31. — C. 17-22.</mixed-citation><mixed-citation xml:lang="en">Kazhina M.V. Beremennost’ na fone ozhireniia: debiut metabolicheskogo sindroma materi i programmirovanie metabolicheskogo sindroma ploda. Okhrana materinstva i detstva. 2018;1(31):17-22. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D-D, Wu F, Zhang L-Y, et al. Effects of dietary n-3 PUFA levels in early life on susceptibility to high-fat-diet-induced metabolic syndrome in adult mice. J Nutr Biochem. 2021;89(2):108578. doi: https://doi.org/10.1016/j.jnutbio.2020.108578</mixed-citation><mixed-citation xml:lang="en">Wang D-D, Wu F, Zhang L-Y, et al. Effects of dietary n-3 PUFA levels in early life on susceptibility to high-fat-diet-induced metabolic syndrome in adult mice. J Nutr Biochem. 2021;89(2):108578. doi: https://doi.org/10.1016/j.jnutbio.2020.108578</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal P, Dhana K, Barnes LL, et al. Unhealthy foods may attenuate the beneficial relation of a Mediterranean diet to cognitive decline. Alzheimer’s Dement. 2021;17(7):1157-1165. doi: https://doi.org/10.1002/alz.12277</mixed-citation><mixed-citation xml:lang="en">Agarwal P, Dhana K, Barnes LL, et al. Unhealthy foods may attenuate the beneficial relation of a Mediterranean diet to cognitive decline. Alzheimer’s Dement. 2021;17(7):1157-1165. doi: https://doi.org/10.1002/alz.12277</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Noble EE, Olson CA, Davis E, et al. Gut microbial taxa elevated by dietary sugar disrupt memory function. Transl Psychiatry. 2021;11(1):194. doi: https://doi.org/10.1038/s41398-021-01309-7</mixed-citation><mixed-citation xml:lang="en">Noble EE, Olson CA, Davis E, et al. Gut microbial taxa elevated by dietary sugar disrupt memory function. Transl Psychiatry. 2021;11(1):194. doi: https://doi.org/10.1038/s41398-021-01309-7</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Zhuang Z-Q, Shen L-L, Li W-W, et al. Gut Microbiota is Altered in Patients with Alzheimer’s Disease. J Alzheimer’s Dis. 2018;63(4):1337-1346. doi: https://doi.org/10.3233/JAD-180176</mixed-citation><mixed-citation xml:lang="en">Zhuang Z-Q, Shen L-L, Li W-W, et al. Gut Microbiota is Altered in Patients with Alzheimer’s Disease. J Alzheimer’s Dis. 2018;63(4):1337-1346. doi: https://doi.org/10.3233/JAD-180176</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Więckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev. 2021;70(4):101397. doi: https://doi.org/10.1016/j.arr.2021.101397</mixed-citation><mixed-citation xml:lang="en">Więckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev. 2021;70(4):101397. doi: https://doi.org/10.1016/j.arr.2021.101397</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci. 2007;104(3):979-984. doi: https://doi.org/10.1073/pnas.0605374104</mixed-citation><mixed-citation xml:lang="en">Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci. 2007;104(3):979-984. doi: https://doi.org/10.1073/pnas.0605374104</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Guida S, Venema K. Gut microbiota and obesity: Involvement of the adipose tissue. J Funct Foods. 2015;14(3):407-423. doi: https://doi.org/10.1016/j.jff.2015.02.014</mixed-citation><mixed-citation xml:lang="en">Guida S, Venema K. Gut microbiota and obesity: Involvement of the adipose tissue. J Funct Foods. 2015;14(3):407-423. doi: https://doi.org/10.1016/j.jff.2015.02.014</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Belizário JE, Faintuch J, Garay-Malpartida M. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm. 2018;2018(3):1-12. doi: https://doi.org/10.1155/2018/2037838</mixed-citation><mixed-citation xml:lang="en">Belizário JE, Faintuch J, Garay-Malpartida M. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm. 2018;2018(3):1-12. doi: https://doi.org/10.1155/2018/2037838</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Маневич Т.М. Кишечная микробиота, боль, деменция // Российский журнал боли. — 2022. — Т. 20. — №1. — С. 48-55. doi: https://doi.org/10.17116/pain20222001148</mixed-citation><mixed-citation xml:lang="en">Manevich TM. Intestinal microbiota, pain, dementia. Russ J Pain. 2022;20(1):48. (In Russ.). doi: https://doi.org/10.17116/pain20222001148</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Карпеева Ю.С., Новикова В.П., Хавкин А.И., и др. Микробиота и болезни человека: возможности диетической коррекции // Российский вестник перинатологии и педиатрии. — 2020. — Т. 65. — №5. — С. 116-125. doi: https://doi.org/10.21508/1027-4065-2020-65-5-116-125</mixed-citation><mixed-citation xml:lang="en">Karpeeva YuS, Novikova VP, Khavkin AI, et al. Microbiota and human diseases: dietary correction. Russian Bulletin of Perinatology and Pediatrics. 2020;65(5):116-125. (In Russ.). doi: https://doi.org/10.21508/1027-4065-2020-65-5-116-125</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci. 2005;102(31):11070-11075. doi: https://doi.org/10.1073/pnas.0504978102</mixed-citation><mixed-citation xml:lang="en">Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci. 2005;102(31):11070-11075. doi: https://doi.org/10.1073/pnas.0504978102</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Stephens RW, Arhire L, Covasa M. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity. Obesity. 2018;26(5):801-809. doi: https://doi.org/10.1002/oby.22179</mixed-citation><mixed-citation xml:lang="en">Stephens RW, Arhire L, Covasa M. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity. Obesity. 2018;26(5):801-809. doi: https://doi.org/10.1002/oby.22179</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep. 2015;4(2):250-261. doi: https://doi.org/10.1007/s13679-015-0152-0</mixed-citation><mixed-citation xml:lang="en">Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep. 2015;4(2):250-261. doi: https://doi.org/10.1007/s13679-015-0152-0</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Юдина Ю.В., Корсунский А.А., Аминова А.И., и др. Микробиота кишечника как отдельная система организма // Доказательная гастроэнтерология. — 2019. — Т. 8. — №4-5. — С. 36-43. doi: https://doi.org/10.17116/dokgastro2019804-05136</mixed-citation><mixed-citation xml:lang="en">Yudina YV., Korsunsky AA, Aminova AI, et al. Gut microbiota as a separate body system. Dokazatel’naya Gastroenterol. 2019;8(4-5):36-43. (In Russ.). doi: https://doi.org/10.17116/dokgastro2019804-05136</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Belizário JE, Faintuch J, Garay-Malpartida M. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm. 2018;2018(4-5):1-12. doi: https://doi.org/10.1155/2018/2037838</mixed-citation><mixed-citation xml:lang="en">Belizário JE, Faintuch J, Garay-Malpartida M. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm. 2018;2018(4-5):1-12. doi: https://doi.org/10.1155/2018/2037838</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen AK, Hansen CHF, Krych L, Nielsen DS. Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol. 2014;20(47):17727-17736. doi: https://doi.org/10.3748/wjg.v20.i47.17727</mixed-citation><mixed-citation xml:lang="en">Hansen AK, Hansen CHF, Krych L, Nielsen DS. Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol. 2014;20(47):17727-17736. doi: https://doi.org/10.3748/wjg.v20.i47.17727</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Pedersen R, Ingerslev H-C, Sturek M, et al. Characterisation of Gut Microbiota in Ossabaw and Göttingen Minipigs as Models of Obesity and Metabolic Syndrome. PLoS One. 2013;8(2):e56612. doi: https://doi.org/10.1371/journal.pone.0056612</mixed-citation><mixed-citation xml:lang="en">Pedersen R, Ingerslev H-C, Sturek M, et al. Characterisation of Gut Microbiota in Ossabaw and Göttingen Minipigs as Models of Obesity and Metabolic Syndrome. PLoS One. 2013;8(2):e56612. doi: https://doi.org/10.1371/journal.pone.0056612</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014;588(22):4223-4233. doi: https://doi.org/10.1016/j.febslet.2014.09.039</mixed-citation><mixed-citation xml:lang="en">Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014;588(22):4223-4233. doi: https://doi.org/10.1016/j.febslet.2014.09.039</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Guevara‐Cruz M, Flores‐López AG, Aguilar‐López M, et al. Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome. J Am Heart Assoc. 2019;8(17):1720-1724. doi: https://doi.org/10.1161/JAHA.119.012401</mixed-citation><mixed-citation xml:lang="en">Guevara‐Cruz M, Flores‐López AG, Aguilar‐López M, et al. Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome. J Am Heart Assoc. 2019;8(17):1720-1724. doi: https://doi.org/10.1161/JAHA.119.012401</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes. 2008;32(11):1720-1724. doi: https://doi.org/10.1038/ijo.2008.155</mixed-citation><mixed-citation xml:lang="en">Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes. 2008;32(11):1720-1724. doi: https://doi.org/10.1038/ijo.2008.155</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Mai V, McCrary QM, Sinha R, Glei M. Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J. 2009;8(1):49. doi: https://doi.org/10.1186/1475-2891-8-49</mixed-citation><mixed-citation xml:lang="en">Mai V, McCrary QM, Sinha R, Glei M. Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J. 2009;8(1):49. doi: https://doi.org/10.1186/1475-2891-8-49</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Patil DP, Dhotre DP, Chavan SG, et al. Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci. 2012;37(4):647-657. doi: https://doi.org/10.1007/s12038-012-9244-0</mixed-citation><mixed-citation xml:lang="en">Patil DP, Dhotre DP, Chavan SG, et al. Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci. 2012;37(4):647-657. doi: https://doi.org/10.1007/s12038-012-9244-0</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Ruan Y, Sun J, He J, et al. Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. PLoS One. 2015;10(7):e0132121. doi: https://doi.org/10.1371/journal.pone.0132121</mixed-citation><mixed-citation xml:lang="en">Ruan Y, Sun J, He J, et al. Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. PLoS One. 2015;10(7):e0132121. doi: https://doi.org/10.1371/journal.pone.0132121</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Basak S, Banerjee A, Pathak S, Duttaroy AK. Dietary Fats and the Gut Microbiota: Their impacts on lipid-induced metabolic syndrome. J Funct Foods. 2022;91:105026. doi: https://doi.org/10.1016/j.jff.2022.105026</mixed-citation><mixed-citation xml:lang="en">Basak S, Banerjee A, Pathak S, Duttaroy AK. Dietary Fats and the Gut Microbiota: Their impacts on lipid-induced metabolic syndrome. J Funct Foods. 2022;91:105026. doi: https://doi.org/10.1016/j.jff.2022.105026</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Творогова Т.М., Корниенко Е.А. Микронутритивный дефицит и кишечная микробиота как факторы, влияющие на иммунный ответ, роль микробиоты и ее метаболитов // Эффективная фармакотерапия. — 2020. — Т. 16. — №10. — С. 6-11. doi: https://doi.org/10.33978/2307-3586-2020-16-10-6-11</mixed-citation><mixed-citation xml:lang="en">Tvorogova TM, Korniyenko YA. Micronutritive Deficiency and Intestinal Microbiota as Factors Affecting the Immune Response, the Role of the Microbiota and Its Metabolites. Eff Pharmacother. 2020;16(10):6-11. (In Russ.). doi: https://doi.org/10.33978/2307-3586-2020-16-10-6-11</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Крылова И.А., Купаев В.И., Лямин А.В., и др. Метапребиотики — новая возможность коррекции микробиоты кишечника // Наука и инновации в медицине. — 2021. — Т. 6. — №1. — С. 29-32. doi: https://doi.org/10.35693/2500-1388-2021-6-1-29-32</mixed-citation><mixed-citation xml:lang="en">Кrylova IА, Kupaev VI, Lyamin АV. et al. Meta-prebiotics: a new way to control the intestinal microbiota. Sci Innov Med. 2021;6(1):29-32. (In Russ.). doi: https://doi.org/10.35693/2500-1388-2021-6-1-29-32</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Sun W-L, Li X-Y, Dou H-Y, et al. Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. Cell Rep. 2021;36(9):109641. doi: https://doi.org/10.1016/j.celrep.2021.109641</mixed-citation><mixed-citation xml:lang="en">Sun W-L, Li X-Y, Dou H-Y, et al. Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. Cell Rep. 2021;36(9):109641. doi: https://doi.org/10.1016/j.celrep.2021.109641</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang P, Zheng W, Sun X, et al. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice. Int J Biol Macromol. 2021;167(9):1587-1597. doi: https://doi.org/10.1016/j.ijbiomac.2020.11.116</mixed-citation><mixed-citation xml:lang="en">Jiang P, Zheng W, Sun X, et al. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice. Int J Biol Macromol. 2021;167(9):1587-1597. doi: https://doi.org/10.1016/j.ijbiomac.2020.11.116</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Reichardt F, Chassaing B, Nezami BG, et al. Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharideinduced TLR4 signalling. J Physiol. 2017;595(5):1831-1846. doi: https://doi.org/10.1113/JP273269</mixed-citation><mixed-citation xml:lang="en">Reichardt F, Chassaing B, Nezami BG, et al. Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharideinduced TLR4 signalling. J Physiol. 2017;595(5):1831-1846. doi: https://doi.org/10.1113/JP273269</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Guo J, Han X, Huang W, et al. Interaction between IgA and gut microbiota and its role in controlling metabolic syndrome. Obes Rev. 2021;22(4):1831-1846. doi: https://doi.org/10.1111/obr.13155</mixed-citation><mixed-citation xml:lang="en">Guo J, Han X, Huang W, et al. Interaction between IgA and gut microbiota and its role in controlling metabolic syndrome. Obes Rev. 2021;22(4):1831-1846. doi: https://doi.org/10.1111/obr.13155</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce-Keller AJ, Salbaum JM, Luo M, et al. Obesetype Gut Microbiota Induce Neurobehavioral Changes in the Absence of Obesity. Biol Psychiatry. 2015;77(7):607-615. doi: https://doi.org/10.1016/j.biopsych.2014.07.012</mixed-citation><mixed-citation xml:lang="en">Bruce-Keller AJ, Salbaum JM, Luo M, et al. Obesetype Gut Microbiota Induce Neurobehavioral Changes in the Absence of Obesity. Biol Psychiatry. 2015;77(7):607-615. doi: https://doi.org/10.1016/j.biopsych.2014.07.012</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Morales P, Fujio S, Navarrete P, et al. Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers. Clin Transl Gastroenterol. 2016;7(4):e161. doi: https://doi.org/10.1038/ctg.2016.20</mixed-citation><mixed-citation xml:lang="en">Morales P, Fujio S, Navarrete P, et al. Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers. Clin Transl Gastroenterol. 2016;7(4):e161. doi: https://doi.org/10.1038/ctg.2016.20</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Klingbeil E, de La Serre CB. Microbiota modulation by eating patterns and diet composition: impact on food intake. Am J Physiol Integr Comp Physiol. 2018;315(6):R1254-R1260. doi: https://doi.org/10.1152/ajpregu.00037.2018</mixed-citation><mixed-citation xml:lang="en">Klingbeil E, de La Serre CB. Microbiota modulation by eating patterns and diet composition: impact on food intake. Am J Physiol Integr Comp Physiol. 2018;315(6):R1254-R1260. doi: https://doi.org/10.1152/ajpregu.00037.2018</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Łuc M, Misiak B, Pawłowski M, et al. Gut microbiota in dementia. Critical review of novel findings and their potential application. Prog Neuro-Psychopharmacology Biol Psychiatry. 2021;104(6):110039. doi: https://doi.org/10.1016/j.pnpbp.2020.110039</mixed-citation><mixed-citation xml:lang="en">Łuc M, Misiak B, Pawłowski M, et al. Gut microbiota in dementia. Critical review of novel findings and their potential application. Prog Neuro-Psychopharmacology Biol Psychiatry. 2021;104(6):110039. doi: https://doi.org/10.1016/j.pnpbp.2020.110039</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: Implications for future treatment. J Allergy Clin Immunol. 2008;121(6):1344-1350. doi: https://doi.org/10.1016/j.jaci.2008.02.037</mixed-citation><mixed-citation xml:lang="en">Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: Implications for future treatment. J Allergy Clin Immunol. 2008;121(6):1344-1350. doi: https://doi.org/10.1016/j.jaci.2008.02.037</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков П.С., Черевко Н.А., Денисенко О.А., и др. Роль Candida albicans в развитии пищевой гиперчувствительности и метаболических нарушений // Российский иммунологический журнал. — 2019. — Т. 13. — №2-2. — С. 1057-1059. doi: https://doi.org/10.31857/S102872210006474-6</mixed-citation><mixed-citation xml:lang="en">Novikov PS, Cherevko NA, Denisenko OA, et al. Rol’ Candida albicans v razvitii pishchevoi giperchuvstvitel’nosti i metabolicheskikh narushenii. Rossiiskii immunologicheskii zhurnal. 2019;13(2-2):1057-1059. (In Russ.). doi: https://doi.org/10.31857/S102872210006474-6</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Добродеева Л.К. Активность иммунных реакций в зависимости от характера питания и состояния органов желудочно-кишечного тракта. — Екатеринбург: УрО РАН; 2018. — 172 с.</mixed-citation><mixed-citation xml:lang="en">Dobrodeeva L.K. Aktivnost’ immunnykh reaktsii v zavisimosti ot kharaktera pitaniia i sostoianiia organov zheludochno-kishechnogo trakta. — Ekaterinburg: UrO RAN; 2018. 172 p. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
